Tenaya Therapeutics, Inc. (TNYA) Tops Q2 EPS by 5c

Tenaya Therapeutics, Inc. (NASDAQ: TNYA) reported Q2 EPS of ($0.45), $0.05 better than the analyst estimate of ($0.50).

For earnings history and earnings-related data on Tenaya Therapeutics, Inc. (TNYA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
• OneMain (OMF) Reiterated at Market Outperform by Citizens on Updated Estimates